Robert G. KORNELUK,Eric C. LACASSE,Shawn T. BEUG,Vera A. TANG
申请号：
US15113634
公开号：
US20170239347A1
申请日:
2015.01.26
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention includes methods and compositions for enhancing the efficacy of SMCs in the treatment of cancer. In particular, the present invention includes methods and compositions for combination therapies that include an SMC and at least a second agent that stimulates one or more apoptotic or immune pathways. The second agent may be, e.g., an immunostimulatory compound or oncolytic virus.
